REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laekna, Inc. (来凯医药有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Biological Product (except Diagnostic) Manufacturing
Full name: Laekna, Inc. Profile Updated: March 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Laekna, Inc. (来凯医药有限公司) is based in China. The head office is in Yuyao. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on July 29, 2016. The total number of employees is currently 83 (2025). There was a total growth of 47.37% in Laekna, Inc. (来凯医药有限公司)’s total assets over the same period.

Headquarters
3-2-467, 5 Xingbin Road (Lin Li Center), Sino-Italy Ningbo Ecological Park, Yuyao
Yuyao; Zhejiang;

Contact Details: Purchase the Laekna, Inc. (来凯医药有限公司) report to view the information.

Website: http://www.laekna.com

Basic Information
Total Employees:
Purchase the Laekna, Inc. (来凯医药有限公司) report to view the information.
Outstanding Shares:
Purchase the Laekna, Inc. (来凯医药有限公司) report to view the information.
Registered Capital:
Purchase the Laekna, Inc. (来凯医药有限公司) report to view the information.
Financial Auditors:
Purchase the Laekna, Inc. (来凯医药有限公司) report to view the information.
Incorporation Date:
July 29, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
6.99%
Purchase this report to view the information.
6.95%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Laekna Limited (Hong Kong SAR, China)
100%
Laekna Llc (United States)
100%
Laekna Pharmaceutical Shanghai Co., Ltd.
Company Performance
Financial values in the chart are available after Laekna, Inc. (来凯医药有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total Operating Revenue
22000.57%▲
Operating Profit
9.59%▲
EBITDA
9.9%▲
Net Profit/Loss for the Period
9.82%▲
Total Assets
47.37%▲
Total Equity
46.67%▲
Return on Equity (ROE)
12.17%▲
Debt / Equity
-2725%▼
Quick Ratio
64.55%▲
Cash Ratio
1.13%▲

Similar companies

Zjamp Group Co., Ltd.
 
Sinopharm Group Company Limited
Shanghai Pharmaceuticals Holding Co.,Ltd
 
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
JD Health International Inc.
 
Nanjing Pharmaceutical Company Limited
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
 
Paranovus Entertainment Technology Ltd.
Guangzhou Innogen Pharmaceutical Group Co. Ltd.
 
Novabridge Biosciences

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo